Keyphrases
Japan
100%
Treatment Strategy
100%
Osteoarthritis
100%
Cost-effectiveness Analysis
100%
Opioid Medication
100%
Quality-adjusted Life Years
54%
Hip Osteoarthritis
36%
Knee Osteoarthritis
36%
Non-opioid Treatment
36%
Opioid Treatment
36%
Health Status
27%
Transition Probability
18%
Incremental Cost-effectiveness Ratio
18%
Adverse Events
9%
Literature Database
9%
Cost-effectiveness
9%
Treatment Efficacy
9%
Sensitivity Analysis
9%
Opioids
9%
Monotherapy
9%
Database Analysis
9%
Literature Review Analysis
9%
Treatment Pathways
9%
Probabilistic Sensitivity Analysis
9%
Targeted Review
9%
Japanese-specific
9%
Markov Cohort Model
9%
Incremental Cost
9%
One-way Sensitivity Analysis
9%
Degree of Uncertainty
9%
Utility Value
9%
Event Value
9%
Medicine and Dentistry
Drug Therapy
100%
Cost-Effectiveness Analysis
100%
Osteoarthritis
100%
Opiate
100%
Quality Adjusted Life Year
42%
Health Care Cost
21%
Knee
21%
Health Status
21%
Hip
21%
Adverse Event
7%
Monotherapy
7%
Base
7%
Knee Osteoarthritis
7%
Hip Osteoarthritis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Osteoarthritis
100%
Opiate
100%
Health Status
21%
Adverse Event
7%
Base
7%
Monotherapy
7%
Hip Osteoarthritis
7%
Knee Osteoarthritis
7%